MPM BIOVENTURES V, L.P.

Insider CIK 1482716 · CNAT 10% owner · PETX 10% owner · VSTM · CERC 10% owner · RYTM 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
RYTM RHYTHM PHARMACEUTICALS, IN	C Conversion deriv	2017-10-10	2017-10-11	15,887,703	—	$0	0	SEC↗
RYTM RHYTHM PHARMACEUTICALS, IN	C Conversion deriv	2017-10-10	2017-10-11	7,651,831	—	$0	0	SEC↗
RYTM RHYTHM PHARMACEUTICALS, IN	C Conversion	2017-10-10	2017-10-11	2,567,014	—	$0	2,596,392	SEC↗
RYTM RHYTHM PHARMACEUTICALS, IN	P Buy	2017-10-10	2017-10-11	100,000	$17.00	$1.70M	2,696,392	SEC↗
CERC Cerecor Inc.	C Conversion deriv	2015-10-20	2015-10-20	16,672,224	—	$0	0	SEC↗
CERC Cerecor Inc.	C Conversion	2015-10-20	2015-10-20	595,436	—	$0	595,436	SEC↗
PETX ARATANA THERAPEUTICS, INC.	S Sale	2014-03-10	2014-03-12	600,000	$20.02	$12.01M	2,751,048	SEC↗
PETX ARATANA THERAPEUTICS, INC.	J Other	2014-03-03	2014-03-05	20,876	—	$0	38,386	SEC↗
PETX ARATANA THERAPEUTICS, INC.	J Other	2014-03-03	2014-03-05	15,310	—	$0	17,937	SEC↗
PETX ARATANA THERAPEUTICS, INC.	J Other	2014-03-03	2014-03-05	20,876	—	$0	22,767	SEC↗
PETX ARATANA THERAPEUTICS, INC.	J Other	2014-03-03	2014-03-05	12,247	—	$0	12,393	SEC↗
PETX ARATANA THERAPEUTICS, INC.	J Other	2014-03-03	2014-03-05	20,876	—	$0	26,713	SEC↗
PETX ARATANA THERAPEUTICS, INC.	J Other	2014-03-03	2014-03-05	1,000,000	—	$0	3,351,048	SEC↗
PETX ARATANA THERAPEUTICS, INC.	J Other	2014-03-03	2014-03-05	37,117	—	$0	37,117	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	8,333,334	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	265,837	—	$0	0	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion deriv	2013-07-30	2013-08-01	32,220	—	$0	32,220	SEC↗
CNAT Conatus Pharmaceuticals In	C Conversion	2013-07-30	2013-08-01	1,010,099	—	$0	1,010,099	SEC↗
CNAT Conatus Pharmaceuticals In	P Buy	2013-07-30	2013-08-01	165,265	$11.00	$1.82M	1,192,080	SEC↗
CNAT Conatus Pharmaceuticals In	J Other	2013-07-30	2013-08-01	16,716	$11.00	$183.9K	1,026,815	SEC↗
PETX ARATANA THERAPEUTICS, INC.	C Conversion deriv	2013-07-02	2013-07-02	375,000	—	$0	0	SEC↗
PETX ARATANA THERAPEUTICS, INC.	C Conversion deriv	2013-07-02	2013-07-02	1,333,333	—	$0	0	SEC↗
PETX ARATANA THERAPEUTICS, INC.	C Conversion deriv	2013-07-02	2013-07-02	4,000,000	—	$0	0	SEC↗
PETX ARATANA THERAPEUTICS, INC.	P Buy	2013-07-02	2013-07-02	500,000	$6.00	$3.00M	4,351,050	SEC↗
PETX ARATANA THERAPEUTICS, INC.	C Conversion	2013-07-02	2013-07-02	225,631	—	$0	3,851,050	SEC↗
PETX ARATANA THERAPEUTICS, INC.	C Conversion	2013-07-02	2013-07-02	802,246	—	$0	3,625,419	SEC↗
PETX ARATANA THERAPEUTICS, INC.	C Conversion	2013-07-02	2013-07-02	2,406,739	—	$0	2,823,173	SEC↗
VSTM Verastem, Inc.	C Conversion deriv	2012-02-01	2012-02-03	266,666	—	$0	0	SEC↗
VSTM Verastem, Inc.	C Conversion deriv	2012-02-01	2012-02-03	2,500,000	—	$0	0	SEC↗
VSTM Verastem, Inc.	C Conversion deriv	2012-02-01	2012-02-03	4,000,000	—	$0	0	SEC↗
VSTM Verastem, Inc.	C Conversion	2012-02-01	2012-02-03	1,933,333	—	$0	1,933,333	SEC↗
VSTM Verastem, Inc.	P Buy	2012-02-01	2012-02-03	100,000	$10.00	$1.00M	2,033,333	SEC↗